Navigation Links
Phase Genomics and Phyzen Co., Ltd. Announce Korean Distribution Partnership
Date:4/11/2017

Today, Phase Genomics and Phyzen Co., Ltd. have announced an exclusive partnership to deliver Phase Genomics’ Proximo™ Hi-C genome scaffolding service to the Korean market. The deal makes Phyzen the sole distributor of the service in all of South Korea.

“Phyzen’s experience and expertise in the Korean market will be a tremendous asset for further expanding our ability to deliver Proximo Hi-C to scientists and researchers around the world,” said Ivan Liachko, Phase Genomics’ co-founder and CEO. “With this partnership, biological research in South Korea is poised to make significant leaps forward.”

The Proximo Hi-C service builds on Hi-C-based genome scaffolding technology invented by members of the Phase Genomics founding team in 2013. Proximo has been used on hundreds of genome assemblies to date, including a goat genome recently published in Nature Genetics and highlighted in The Atlantic. This goat genome represents the most contiguous mammalian de novo assembly ever constructed, and the company notes many of its other customers are preparing manuscripts of their own on numerous plants and animals assembled with Proximo Hi-C.

“We have been impressed by the unparalleled capabilities of Phase Genomics’ Proximo Hi-C since we first saw its results,” said Kyoung-Dae Kang, CEO of Phyzen. “This technology will be of great importance to the Korean scientific community, and we’re thrilled to partner with Phase Genomics to be the exclusive providers of this service in South Korea.”

South Korean researchers may now contact Phyzen via their website to obtain more information about how to access Proximo Hi-C services. General information as well as instructions for obtaining the service outside South Korea can be found on Phase Genomics’ website.

ABOUT PHASE GENOMICS - Phase Genomics, Inc. is based in Seattle, WA and was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower researchers of all kinds with state-of-the-art genomic tools. The company serves academic and commercial researchers in diverse fields and industries.

Website: http://www.phasegenomics.com
Contact: info(at)phasegenomics(dot)com

ABOUT PHYZEN CO. LTD. - Phyzen Co., Ltd. is a bioinformatics and genomics service provider based in Seongnam, South Korea. The company was founded in 2013 by a team of genome scientists, bioinformaticians, and entrepreneurs. Phyzen closely works together with diverse researchers in university, government institute and private sector to provide the better solutions in genome research.

Website: http://www.phyzen.com
Contact: info(at)phyzen(dot)com

Read the full story at http://www.prweb.com/releases/2017/04/prweb14225455.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Self-assembled nanostructures enable a low-power phase-change memory for mobile electronic devices
3. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
4. Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
5. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
6. irisnote Announces Successful Conclusion of Beta Test Phase
7. Risk Assessment and Mitigation in Phase I Trials in High Risk Compounds: A Continuously Developing Process, new life science webinar hosted by Xtalks
8. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
9. Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
10. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
11. Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation Phase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... , ... The award-winning American Farmer television series will feature 3 Bar Biologics ... at 8:30aET on RFD-TV. , With global population estimates nearing ten billion people ... to feed a growing nation. At the same time, many of our valuable resources ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface electromyography (sEMG) ... tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter phase III ...
(Date:10/7/2017)...  The 2017 Nobel Prize in Chemistry recognizes ... Joachim Frank and Richard Henderson ... (cryo-EM) have helped to broaden the use ... The winners worked with systems manufactured by Thermo ... resolved, three-dimensional images of protein structures that lead ...
Breaking Biology Technology:
(Date:6/30/2017)... , June 30, 2017 Today, American ... and supplier of face and eye tracking software, ... Product provider program. "Artificial intelligence ... way to monitor a driver,s attentiveness levels while ... being able to detect fatigue and prevent potential ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
Breaking Biology News(10 mins):